Riskpilot← Back to searchSign inGet full accessSWEMAC OSMEDIC ApS
APSActiveCVR 33583818Lyngebæksgårdalle 2Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20119 employees
Revenue 2025
DKK 19,4M
-21% vs 2024
EBITDA margin
55.9%
-31% vs 2024
Equity ratio
40.8%
Financial strength
Net profit 2025
DKK 8,1M
-32% vs 2024
| Revenue | DKK 19,4M | -21% |
| EBITDA | DKK 10,8M | -31% |
| Net profit | DKK 8,1M | -32% |
| Total assets | DKK 20,7M | -7% |
| Equity | DKK 8,4M | -31% |
| Employees | 9 | — |
Legal name
SWEMAC OSMEDIC ApS
CVR number
33583818
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
24. marts 2011
Share capital
DKK 290.698
Employees
9 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør i forening med et bestyrelsesmedlem
Company purpose
Selskabets formål er at handle med medicinske produkter.
Address
Lyngebæksgårdalle 2
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 14.339 | 16.644 | 16.024 | 14.359 | 16.715 | 18.319 | 17.626 | 15.870 | 19.395 | 19.058 | 16.517 | 14.779 | 24.679 | 19.390 |
| Staff expenses | -6.416 | -6.564 | -6.429 | -7.143 | -8.610 | -8.007 | -8.533 | -8.219 | -8.162 | -8.232 | -8.279 | -7.917 | -8.874 | -8.550 |
| EBITDA | 7.924 | 10.080 | 9.595 | 7.217 | 8.105 | 10.311 | 9.093 | 7.651 | 11.233 | 10.826 | 8.238 | 6.862 | 15.806 | 10.840 |
| Depreciation & amort. | 453 | 358 | 216 | 109 | 139 | -194 | -195 | -402 | -421 | -343 | -325 | -440 | -371 | -275 |
| EBIT | 7.471 | 9.722 | 9.380 | 7.107 | 7.966 | 10.118 | 8.898 | 7.249 | 10.812 | 10.483 | 7.913 | 6.422 | 15.435 | 10.565 |
| Net financials | -354 | -41 | -406 | -259 | -16 | -106 | -44 | -129 | -64 | -81 | -145 | -102 | -76 | -107 |
| Profit before tax | 7.117 | 9.681 | 8.974 | 6.848 | 7.949 | 10.012 | 8.854 | 7.120 | 10.748 | 10.401 | 7.768 | 6.320 | 15.359 | 10.457 |
| Tax | 1.911 | 2.603 | 2.322 | 1.422 | 1.770 | 2.229 | 1.952 | 1.598 | 2.442 | 2.293 | 1.726 | 1.398 | 3.396 | 2.310 |
| Net profit | 5.206 | 7.078 | 6.652 | 5.426 | 6.179 | 7.783 | 6.902 | 5.522 | 8.305 | 8.108 | 6.042 | 4.921 | 11.962 | 8.147 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 16.789 | 15.717 | 15.149 | 16.063 | 16.156 | 14.717 | 13.935 | 17.050 | 20.593 | 18.635 | 15.496 | 17.131 | 22.320 | 20.676 |
| Equity | 5.497 | 7.369 | 6.942 | 5.717 | 6.470 | 8.074 | 7.192 | 5.813 | 8.596 | 8.399 | 6.333 | 5.212 | 12.253 | 8.438 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 295 | 608 | 412 | 302 | 198 | 197 | 87 |
| Short-term debt | 11.293 | 8.349 | 8.207 | 10.346 | 9.686 | 6.644 | 6.743 | 10.943 | 11.389 | 9.824 | 8.860 | 11.720 | 9.869 | 12.151 |
| Total debt | 11.293 | 8.349 | 8.207 | 10.346 | 9.686 | 6.644 | 6.743 | 11.238 | 11.997 | 10.236 | 9.163 | 11.918 | 10.067 | 12.239 |
EBITDA margin
55.9%
This company
15.8%
Market median
+254% vs market
20122025
Equity ratio
40.8%
This company
38.2%
Market median
+7% vs market
20122025
Return on equity
96.6%
This company
18.4%
Market median
+425% vs market
20122025
Net profit margin
42.0%
This company
8.1%
Market median
+419% vs market
20122025
Asset turnover
0.94×
This company
1.12×
Market median
+16% vs market
20122025
Debt / equity
1.45×
This company
0.62×
Market median
-134% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
OE Chief Executive Officer | Chief Executive Officer | 2011 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2017 | — | — | |
| Board of Directors | 2011 | — | — | |
| Board of Directors | 2025 | — | — | |
| Chairman | 2011 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
SWEMAC ORTHOPAEDICS ApS | Company | 50.0% | 50.0% | 2011 |
OSMEDIC ApS | Company | 33.3% | 33.3% | 2011 |
| Individual | 50.0% | 50.0% | 2011 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
OSMEDIC HOLDING ApS
SWEMAC OSMEDIC ApS Board members of SWEMAC OSMEDIC ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ole Emanuel Svendsen | Chief Executive Officer | 0 companies |
| Lars Johan Henrik Hansson | Chairman | 0 companies |
| Mats Fransson | Board of Directors | 0 companies |
| Martin Sjögren | Board of Directors | 0 companies |
| Christer Lennart Lundkvist | Chairman | 0 companies |